Ads
related to: merkel cell carcinoma- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- Patient Resources
Find Patient Resources
On The Official Site.
- FAQs
Search results
Study Examines Merkel Cell Carcinoma in Non-White Hispanics
Medscape· 4 days agoThe findings underscore "the importance of considering race/ethnicity in understanding the...
..., in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous...
The Joplin Globe· 5 days agoTAMPA, FL and SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome ...
Staying safe in the sun: tips to prevent skin cancer during summer
WCMH via Yahoo News· 2 days agoCOLUMBUS, Ohio (WCMH) – With summer approaching, many will be going to swimming pools and staying...
TuHURA reports breakthrough in cancer vaccine trial By Investing.com
Investing.com· 4 days ago(NASDAQ:KTRA), has announced positive results from a Phase 1b trial of its leading cancer vaccine...
4 of the most common head and neck skin cancers, and how to identify them
ClickOnDetroit· 7 days agoGetting a sun-kissed tan might look great, but it ultimately causes damage that can lead to skin...
Rural Patients With Melanoma Fare Worse Than Urban Dwellers
Medscape· 2 days agoThe findings come from an analysis of Surveillance, Epidemiology, and End Results (SEER) data over...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoMerus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today ...
Playbux Rolls Out Two New Upgrades to Make its Ecosystem More Universal and Rewarding
Digital Journal· 5 days ago... from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters...
Douglas Kevin Allaire
The Gazette· 3 days agoDouglas Kevin Allaire Iowa City Douglas Kevin Allaire, 75, of Iowa City/Coralville, died Thursday, May 30, 2024 at The Birdhouse …
